Is Immunoglobulin A (IgA) nephropathy associated with epithelial foot process effacement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

IgA nephropathy is associated with epithelial foot process effacement, particularly in cases with significant proteinuria. This association is based on the understanding that IgA nephropathy is primarily characterized by the deposition of IgA immune complexes in the glomerular mesangium, which can lead to podocyte injury and disruption of the glomerular filtration barrier. Foot process effacement, which refers to the flattening and spreading of podocyte foot processes, is an important ultrastructural change that reflects this podocyte injury. Although the provided evidence does not directly address the relationship between IgA nephropathy and foot process effacement, studies on proteinuric kidney diseases, including those referenced in 1, suggest that significant proteinuria is often correlated with the degree of foot process effacement.

Key Points

  • IgA nephropathy is characterized by IgA immune complex deposition in the glomerular mesangium.
  • Podocyte injury and foot process effacement are associated with significant proteinuria in various kidney diseases, including IgA nephropathy.
  • The degree of foot process effacement often correlates with the severity of proteinuria.
  • Electron microscopy examination of kidney biopsy specimens can reveal foot process effacement, while immunofluorescence studies are used to identify diagnostic IgA deposits.

Given the information from 1, which discusses the clinical utility of classifying patients with the FSGS lesion on biopsy, including those with diffuse podocyte foot-process effacement, it's reasonable to infer that similar mechanisms of podocyte injury could be at play in IgA nephropathy, especially in cases with significant proteinuria. However, the direct evidence linking IgA nephropathy with foot process effacement is not explicitly provided in the given studies. Therefore, the recommendation is based on the understanding of the pathophysiological processes involved in proteinuric kidney diseases and the implications of podocyte injury in these conditions, as suggested by studies like 1.

From the Research

Association between IgA Nephropathy and Epithelial Foot Process Effacement

  • IgA nephropathy is a type of kidney disease characterized by the deposition of IgA antibodies in the glomeruli, leading to inflammation and damage to the kidney tissue.
  • Epithelial foot process effacement is a morphological change in the podocytes, which are specialized cells in the glomeruli that play a crucial role in filtering waste and excess fluids from the blood.
  • Studies have investigated the relationship between IgA nephropathy and epithelial foot process effacement, with some findings indicating a correlation between the two:
    • A study published in 2010 found that the extent of foot process effacement was greater in IgA nephropathy cases with proteinuria, and that the degree of foot process effacement was positively correlated with proteinuria 2.
    • Another study published in 2020 found that the severity of foot process effacement was associated with proteinuria in patients with IgA nephropathy, and that the group with diffuse foot process effacement had more severe proteinuria compared to those with rare foot process effacement 3.
    • A study published in 2015 found that proteinuria in IgA nephropathy was significantly correlated with the degree of foot process effacement, and that nephrotic presentation in IgA nephropathy was often associated with severe foot process effacement on electron microscopy 4.
  • However, not all studies have found a correlation between IgA nephropathy and epithelial foot process effacement:
    • A study published in 2004 found that podocyte foot process effacement was not correlated with the level of proteinuria in human glomerulopathies, including IgA nephropathy 5.
    • A study published in 2010 found that foot process effacement was common in IgA nephropathy, but that there was no correlation between foot process effacement and IgA nephropathy subclass or proteinuria group 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.